Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Sep 17;15(9):e0239067. doi: 10.1371/journal.pone.0239067

Association of a genetic risk score with BMI along the life-cycle: Evidence from several US cohorts

Anna Sanz-de-Galdeano 1,2,3,*, Anastasia Terskaya 4, Angie Upegui 1
Editor: David Meyre5
PMCID: PMC7497990  PMID: 32941506

Abstract

We use data from the National Longitudinal Study of Adolescent to Adult Health and from the Health and Retirement Study to explore how the effect of individuals’ genetic predisposition to higher BMI —measured by BMI polygenic scores— changes over the life-cycle for several cohorts. We find that the effect of BMI polygenic scores on BMI increases significantly as teenagers transition into adulthood (using the Add Health cohort, born 1974-83). However, this is not the case for individuals aged 55+ who were born in earlier HRS cohorts (1931-53), whose life-cycle pattern of genetic influence on BMI is remarkably stable as they move into old-age.

Introduction

According to the World Health Organization, worldwide obesity has almost tripled since 1975, and about 39% and 13% of the world’s adult population in 2016 were overweight and obese, respectively. The prevalence of overweight and obesity among children and adolescents has risen even more dramatically from 4% in 1975 to just over 18% in 2016. The equivalent figures only for obesity among children and adolescents are just under 1% in 1975 and about 7% in 2016 (for further details see https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight).

These trends pose serious challenges to both individual and public health because raised BMI is a risk factor for noncommunicable conditions such as high cholesterol, high blood pressure, and coronary heart disease among others (see for instance [1] and the references therein), as well as some cancers [2] and mental illnesses [3, 4]. Additionally, obesity has also been shown to affect health care spending and individuals’ socioeconomic outcomes (see for instance [59]).

Obesity is a many-sided problem with multiple determinants. Hence, its analysis has not been based on a unique perspective, and scholars from several disciplines have contributed to advance knowledge in this area. Social scientists have often focused on the role played by dietary and physical activity patterns that are in turn likely affected by factors like food prices, agricultural policies, income, maternal employment and technology [8, 10, 11]. Importantly, BMI is also affected by genetic factors, and obesity is known to be both highly heritable and polygenic (see for instance [1221]).

In this paper we study how the association between obesity-related genetic variants and BMI varies along the life-cycle or over time across several cohorts in the U.S., where obesity —which affects about 39% of adults— has increased dramatically in the past decades [22], and obesity-related conditions are some of the leading causes of preventable death [1]. We rely on data from two longitudinal representative surveys that contain genome-wide data from respondents: the National Longitudinal Study of Adolescent Health (Add Health hereafter) and the Health and Retirement Study (HRS hereafter). Individuals’ genetic propensity to high BMI is measured using BMI polygenic scores —available in both Add Health and the HRS— constructed based on a recent large-scale genome wide association study for BMI [20]. We study whether the association between BMI and BMI polygenic scores is amplified or mitigated as teenagers transition and settle into adulthood (using Add Health), and as middle-age individuals transition to old-age (using the HRS). We also test whether significantly different patterns arise by childhood socioeconomic status and gender.

Our paper is related to a growing body of research that investigates how individuals’ genetic predisposition to different phenotypes interacts with the environment [23, 24]. In regard to obesity, previous work has shown that childhood socioeconomic status [25], social understandings of body size [26], and individuals’ education [27] moderate the influence of obesity-related genetic variants on obesity-related phenotypes.

Another related strand of the literature has instead used birth cohort as an indicator for exposure to obesogenic environment. Studies for the U.S. have shown that the association between obesity-related genetic variants and BMI is larger among individuals born in later cohorts [25, 2830]. Additionally, [31] and [32] have uncovered an increase in the contribution of genetic factors to variation in BMI for successive birth cohorts in Sweden and Denmark, respectively. This body of results has been interpreted as evidence that individuals’ genetic risk for elevated BMI is amplified when their lives unfold in more obesogenic socio-historical contexts.

This paper focuses on a related question that has received less attention in the literature: is the association between obesity-related genetic variants and obesity-related phenotypes attenuated or strengthened as individuals from the same cohort grow older? [33] have recently shown that the gap in the prevalence of severe obesity between individuals in the top and bottom polygenic score deciles widens during the transition from young adulthood to middle age in the U.S. (using data from the Framingham Offspring and Coronary Artery Risk Development in Young Adults studies), and they have also uncovered a similar pattern in children’s weight from birth to 18 years of age in the UK (using data from the Avon Longitudinal Study of Parents and Children). [34] use the Dunedin Multidisciplinary Health and Development Study, which followed individuals born in 1972-73 in Dunedin (New Zealand) from birth through 38 years, and they find that higher BMI genetic risk scores predict higher BMI growth during childhood (from ages 3 through 13 years), as well as during adulthood (from ages 13 through 38 years).

We add to the limited literature on gene–age interaction effects on BMI [3336] by analysing the effect of BMI polygenic scores as individuals transition from adolescence to young adulthood, and from middle-age to old-age. Moreover, we also analyse whether life-cycle profiles of genetic influence significantly differ by individual characteristics such as gender and socioeconomic status.

We find that the effect of BMI polygenic scores on BMI significantly increases as teenagers transition into adulthood. Specifically, our results for the younger cohort (Add Health, born 1974-84) indicate that a standard deviation increase in BMI polygenic scores is associated with a 4.2% increase in BMI at ages 15-16, while the percentage increase in BMI amounts to 5.7% when individuals are about 28. For the earlier HRS Original cohort (born 1931-41), the effect of BMI polygenic scores amounts to 4.2% when respondents are about 55 years old, and it remains stable while they transition into old-age and eventually reach age 72. We uncover similarly stable life-cycle patterns when focusing on subsequent HRS cohorts (born 1942-53) of 55+ individuals. Our main result is unchanged when analyzing individuals’ life-cycle profiles separately by gender and socioeconomic status: the effect of BMI polygenic scores on BMI peaks in early adulthood.

Interestingly, we also find that, in our later Add Health cohort, the effect of BMI polygenic scores is significantly stronger for individuals with lower childhood socioeconomic status than for their higher socioeconomic status counterparts. In contrast, genetic influence on BMI does not significantly vary by socioeconomic status in any of the earlier HRS cohorts we analyze. We also find that the patterns of genetic influence on BMI do not significantly vary by gender, neither in Add Health nor in the HRS.

The remainder of the paper is organized as follows. The next section describes the data and methods used. The following two sections present respectively the results and discuss some robustness checks. The final section concludes.

Materials and methods

We use data from Add Health and from the HRS. We now describe both datasets, as well as how our working samples have been constructed. We then explain the indicator we use to measure individuals’ genetic predisposition to high BMI (which is available in both datasets), and outline our empirical model.

The HRS dataset

The HRS is a nationally representative longitudinal study of the U.S. public over age 50 conducted every two years since 1992. The HRS collects information on health, socioeconomic background, employment, income, wealth, and other factors relevant to aging and retirement. Genotyping was performed using DNA samples collected during enhanced face-to-face interviews conducted on half of the HRS sample each wave starting in 2006 (and in later waves for new participants). Hence, respondents must have survived at least until genotyping started (2006-08) to be part of our analysis. Detailed information on the HRS genotype data and quality control process can be found at http://hrsonline.isr.umich.edu/modules/meta/xyear/pgs/desc/PGENSCORES3DD.pdf and http://hrsonline.isr.umich.edu/sitedocs/genetics/HRS2_qc_report_SEPT2013.pdf.

The HRS includes several birth cohorts with different entry years. In order to maximize sample size, our benchmark analysis is based on the so-called Original HRS cohort (born between 1931 and 1941) surveyed every two years from 1992 to 2012. However, we stop following this cohort in 2008 to avoid exacerbating potential biases related to mortality selection, which we discuss and address in Section Attrition. Our benchmark analysis relies on a balanced panel sample of 3,181 Original HRS cohort members of European descent who remained in the survey since 1992 until at least 2008, and for whom valid genetic data as well as information regarding their age, sex, height and weight are available. We focus on people of European descent because the BMI polygenic scores we use (described in detail in Section BMI Polygenic Scores) were constructed using the results of a genome-wide association study that mostly relied on a sample of European-descent individuals [20]. Based on self-reported height and weight information we have computed the Body Mass Index for respondents at each wave using the standard formula: weight in kilograms divided by height in meters squared (kg/m2). Individuals are classified as obese if their BMI is 30 or higher following the World Health Organization’s recommendation regarding BMI thresholds for defining obesity in adults [37]. We use self-reports instead of measured values of weight and height because the latter are only available from 2006 onwards (see Section Objective Measurements versus Self-Reports of Weight and Height).

Table 1 provides basic descriptives on age, sex, BMI, and obesity prevalence for our analytic sample. Both mean BMI and obesity prevalence increase with age until individuals are almost 68, and they remain fairly stable thereafter at around 27.8 and 29%, respectively.

Table 1. Summary statistics.

HRS Original Cohort Sample.

Variable Mean Standard Deviation
BMI PGS (Normalized) 0 1.000
BMI 1992 26.951 4.562
BMI 1994 27.055 4.555
BMI 1996 27.267 4.739
BMI 1998 27.536 4.838
BMI 2000 27.689 4.935
BMI 2002 27.779 4.936
BMI 2004 27.871 5.126
BMI 2006 27.909 5.191
BMI 2008 27.825 5.247
Obese 1992 0.217 0.412
Obese 1994 0.235 0.424
Obese 1996 0.242 0.429
Obese 1998 0.263 0.440
Obese 2000 0.277 0.448
Obese 2002 0.289 0.453
Obese 2004 0.296 0.456
Obese 2006 0.292 0.455
Obese 2008 0.290 0.454
Age 1992 55.914 3.147
Age 1994 57.776 3.140
Age 1996 59.781 3.137
Age 1998 61.649 3.135
Age 2000 63.589 3.137
Age 2002 65.733 3.137
Age 2004 67.703 3.143
Age 2006 69.677 3.130
Age 2008 71.679 3.139
Female 0.553 0.497

Statistics based on a balanced panel sample of 3,181 HRS Original cohort members of European descent who remained in the survey from 1992 until at least 2008, and for whom valid genetic data as well as information regarding their age, sex, height and weight are available.

Additionally, we have replicated our analysis using two subsequent HRS cohorts: the War Babies cohort (born 1942-47 and followed from 1998 until 2014), and the Early Baby Boomers cohort (born 1948-55 and followed from 2004 until 2016). The sample selection criteria applied to these cohorts are analogous to those described above for the Original HRS cohort.

The Add Health dataset

Add Health is a school-based longitudinal study of a nationally representative cohort of adolescents in grades 7-12 in the United States during the 1994-95 school year (n = 20,745, age range 12-20 at Wave 1). Add Health is based on a stratified sample of 80 high schools and 52 middle schools with probability of selection proportional to school size. Schools were stratified by region, urbanicity, school type, ethnic mix, and size. Add Health Wave I included an in-school questionnaire (administered to all the students attending the participating schools on the interview day), a more detailed in-home interview (conducted on a random sample of approximately 17 males and 17 females that were randomly selected within school and grade), and a parent questionnaire that was in general answered by the resident mothers of teenagers selected for the in-home sample. In-sample individuals have so far been followed in Waves II (1996, age range 12-21, n = 14,738), III (2000-01, age range 18-27, n = 15,197), IV (2008-09, age range 24-33, n = 15,701), and most recently in Wave V (2016-18, age range 33-43, n = 12,300).

We use data from all the waves of Add Health currently available (Waves I-V). Baseline demographic information on students and their families is obtained from Wave I, while self-reports on weight and height are used to construct BMI at each wave. We do not use objective measurements in our main analysis because they are not available in all waves of Add Health and the HRS. In Section Objective Measurements versus Self-Reports of Weight and Height, we replicate the main results using the objective BMI measures available in both datasets.

Saliva samples for DNA extraction were collected at Wave IV on the full sample. DNA measures were collected at Wave III for the sibling sample of Add Health (see https://www.cpc.unc.edu/projects/addhealth/documentation/guides/PGS_AH1_UserGuide.pdf for a detailed description of genome-wide data collection and quality control protocols).

The formula used to compute BMI is the same for children and adults (kg/m2), but weight, height, and their relation to body fatness change along the life-cycle. All Wave I and most of Wave II respondents were still teenagers, so in those cases we followed the guidelines of the U.S. Centre for Disease Control and Prevention [38] and classified them as obese if their BMI was equal to or greater than the 95th percentile. BMI percentiles by sex and age in the US are taken from the 2000 CDC growth charts, publicly available at https://www.cdc.gov/growthcharts/percentile_data_files.htm. For respondents older than 20 we used instead the obesity definition applied to adults (BMI at or above 30).

Our Add Health analyses rely on a balanced panel sample of 2,730 individuals of European ancestry who remained in the survey from Wave I through Wave V with valid genetic data as well as information on age and sex, and for whom height and weight self-reports are available at all waves.

Table 2 provides basic descriptive statistics for this sample. There is a remarkable increase in both mean BMI (from 22.4 to 29.6) and obesity prevalence (which almost quadruples from 10% to 40%) as individuals transition from adolescence (average age 15.4) to young adulthood (average age 37.3).

Table 2. Summary statistics.

Add Health Sample.

Variable Mean Standard Deviation
BMI PGS (Normalized) -0.000 1.000
BMI 1994/95 22.379 4.442
BMI 1996 23.018 4.772
BMI 2001/02 25.668 5.920
BMI 2008/09 28.104 6.818
BMI 2016/18 29.572 7.329
Obese 1994/95 0.101 0.301
Obese 1996 0.111 0.314
Obese 2001/02 0.189 0.392
Obese 2008/09 0.316 0.465
Obese 2016/18 0.399 0.490
Age 1994/95 15.412 1.702
Age 1996 16.283 1.744
Age 2001/02 21.738 1.747
Age 2008/09 28.253 1.732
Age 2016/18 37.305 1.839
Female 0.473 0.499

Statistics based on a balanced panel sample of 2,730 individuals of European ancestry who remained in the Add Health survey from Wave I through Wave V, and for whom valid genetic data as well as information regarding their age, sex, height and weight are available. Longitudinal weights are used.

BMI polygenic scores

Both Add Health and the HRS currently include BMI polygenic scores, indices that summarize individuals’ genetic risk for elevated BMI (BMIPGS hereafter). These BMI PGS were computed based on the genome wide association (GWAS) study for BMI conducted by [20] on a sample of 339,224 individuals. GWAS scan the entire genome in order to identify single nucleotide polymorphisms (SNPs) that are associated with a particular outcome while using strict significance thresholds to deal with multiple hypothesis testing. SNPs are locations in the genome where there are differences across individuals that can be associated with a particular trait. [39] provide further details regarding the construction of genetic risk scores from GWAS results. [20] used conservative thresholds for statistical significance (Pvalue < 5×10−8) and identified 97 SNPs significantly associated with BMI. BMIPGS are constructed for Add Health and HRS respondents by computing a weighted sum of these SNPs:

BMIPGSi=j=1kβ^jSNPij (1)

where SNPij ∈ {0, 1, 2} is a count of the number of reference alleles for individual i at SNP j, and β^j is the underlying GWAS coefficient estimated by [20] for each SNP associated with BMI. In our Add Health working sample, BMI polygenic scores account for 4.9% (Wave I in 1994-95, mean age 15.4), 5.5% (Wave II in 1996, mean age 16.3), 5.0% (Wave III in 2001-02, mean age 21.7), 6.2% (Wave IV in 2008-09, mean age 28.3) and 5.5% (Wave V in 2016-18, mean age 37.3) of the total variation in BMI. The corresponding figures for our HRS Original cohort analytic sample are: 6.2% (Wave I in 1992, mean age 55.9), 5.9% (Wave II in 1994, mean age 57.8), 6.3% (Wave III in 1996, mean age 59.8), 5.8% (Wave IV in 1998, mean age 61.6), 5.9% (Wave V in 2000, mean age 63.6), 5.8% (Wave VI in 2002, mean age 65.7), 5.9% (Wave VII in 2004, mean age 67.8), 5.5% (Wave VIII in 2004, mean age 69.7) and 5.2% (Wave IX in 2008, mean age 71.7).

Fig 1 plot the (kernel-smoothed) densities of respondents’ BMIPGS in our HRS and Add Health balanced panel samples, respectively. The distributions are approximately normal.

Fig 1. BMI polygenic scores (Normalized) in the HRS original cohort and in add health.

Fig 1

Kernel Density Estimates. This figure displays the kernel-smoothed densities of HRS and Add Health respondents’ BMI polygenic scores in the balanced samples described in Tables 1 and 2, respectively. Number of observations: 3,181 (HRS Original cohort) and 2,730 (Add Health).

Empirical model

Our baseline empirical specification is:

Yic,t=β0+β1BMIPGSic+Xic,tα+ϵic,t, (2)

where Yic,t is the log of BMI of individual i observed at time t who belongs to cohort c (Add Health or the Original HRS cohort in our main analyses). BMIPGSic denotes individuals’ genetic predisposition to high BMI, which is fixed at conception. BMIPGSic is standardized to have mean 0 and standard deviation 1. The vector Xic,t includes age, age squared, and a female dummy, as well as the 10 principal components of the full matrix of genetic data in order to account for population stratification [40, 41]. Our benchmark estimations of are based on self-reported BMI in order to avoid having different (objective vs. self-reported) BMI measurements for different ages. Add Health objective measures are available in Waves II-V (not in Wave I though, when individuals were 16.3 years old on average), while HRS objective measures are only available after 2006. In Section Objective Measurements versus Self-Reports of Weight and Height, we show estimation results based on objective BMI measures (whenever available), and compare them with our benchmark results based on subjective BMI measures. We estimate Eq (2) for the Add Health cohort (born 1974-83) and the Original HRS cohort (born 1931-41) at different points in time: 1994-95, 1996, 2001-02, 2008-09, and 2016-18 for Add Health, and every two years since 1992 until 2008 for the Original HRS cohort. We then analyze whether genetic influence on BMI is amplified or mitigated along the life-cycle for both Add Health respondents (as they transition from adolescence to young adulthood) and Original HRS cohort members (as they transition from middle-age to old-age). Our choice of a log-level model rather than a level-level model in Eq (2) is supported by AIC test results. In line with this, unconditional regression estimates [42] indicate (see S1 Appendix of Fig 1 and 2) that the effect of a standard deviation increase in BMIPGS on BMI is non-linear and it is larger (in absolute terms) the higher the level of BMI.

Main results

Genetic influence on BMI along the life-cycle: General patterns

The results of estimating Eq (2) on the sample of HRS Original cohort members are summarized in Fig 2, which depicts OLS coefficient estimates of β1 (as well as their associated 95% confidence intervals) that measure the estimated percentage increases in BMI associated with a standard deviation increase in BMIPGS as middle-aged adults move into old-age. OLS coefficient estimates and their corresponding standard errors (clustered at the household level) are displayed in S1 Appendix of Table 1. The estimated life-cycle profile indicates that BMI increases associated with a standard deviation increase in BMIPGS remain stable around just above 4% along the life-cycle. Interestingly, a similarly flat life-cycle profile is observed in two subsequent HRS cohorts—the HRS War Babies cohort (born 1942-47) and the Early Baby Boomers cohort (born 1948-1953)—for whom a standard deviation increase in BMIPGS is associated with BMI increases of 5%-6% as they grow older (see Fig 3 in S1 Appendix).

Fig 2. Association between BMI polygenic scores and Log(BMI) along the life-cycle.

Fig 2

HRS Original Cohort. This Figure summarizes the results of estimating Eq 2 on the balanced sample of 3,181 HRS Original cohort members described in Table 1. The dependent variable is Log(BMI). OLS coefficient estimates of β1 as well as their associated 95% confidence intervals are depicted. All regressions include a female dummy, age, age squared, and the first 10 principal components of the full matrix of genetic data. Standard errors are clustered at the household level.

Results for Add Health respondents (Fig 3, S1 Appendix of Table 2) instead suggest that the association between BMIPGS and BMI increases as teenagers become adults. In particular, a standard deviation increase in BMIPGS increases individuals’ BMI by 5.8% by the time they are about 37 in 2016-18, a significantly larger association than the one estimated (4.2%) when they were 15-16 years old (in 1994-95, one sided p-value = 0.002). Interestingly, the association between BMIPGS and log(BMI) appears to stabilize at just above 5.5% at Wave IV (2008-09, average age 28).

Fig 3. Association between BMI polygenic scores and Log(BMI) along the life-cycle.

Fig 3

Add Health Cohort. This Figure summarizes the results of estimating Eq 2 on the balanced sample of 2,730 Add Health cohort members described in Table 2. The dependent variable is Log(BMI). OLS coefficient estimates of β1 as well as their associated 95% confidence intervals are depicted. All regressions include a female dummy, age, age squared, and the first 10 principal components of the full matrix of genetic data. Standard errors are clustered at the school level. Longitudinal weights are used.

Eq (2) is a reduced-form model, and disentangling the mechanisms through which individuals’ BMIPGS may differently affect their BMI at different stages of their lives is beyond the scope of this paper. However, it is worth outlining several potential (and not mutually exclusive) determinants of the pattern of genetic influence we uncover in Add Health. First, homophily may be playing a role both at the genotypic [43] and the phenotypic level [4446]. In the presence of peer effects, homophily may, in turn, lead to social multiplier effects, which would be consistent with the increasing relevance of genetic influence we observe until Add Health individuals approach age 30. These effects may, however, dissipate over time. For instance, [47] find that social-genetic effects on obesity induced by interactions with high school grade-mates are relevant for girls in adolescence, but they dissipate as they grow into adulthood.

Second, the effect of genes on BMI is likely to be altered by environmental factors that change during the life course [2527, 48]. For example, [48] suggests that individuals with high genetic predisposition for obesity are more responsive to food intake than those with low genetic predisposition for obesity. To the extent that the impact of food consumption on BMI accumulates over time, the BMI gap between individuals with low and high BMIPGS can also grow throughout life.

Third, individuals with high BMIPGS may sort into more obesogenic environments. In line with this hypothesis, [48] shows that individuals with a higher genetic predisposition for obesity tend to display a higher demand for food, the effect of which can also be cumulative. In contrast, [49] find that higher BMIPGS are associated with weight loss behaviors, which could reduce genetic influence throughout life.

Fourth, genetically influenced characteristics in children may evoke environmental responses that may in turn alter those characteristics, as genetic and environmental variation are not mutually exclusive [50].

Finally, there may be age-related differences in genetic expression which may result in later manifestations of some genes [51, 52].

Genetic influence on BMI along the life-cycle: Patterns by gender and socioeconomic background

We now explore whether the life-cycle patterns we have uncovered so far significantly vary by gender and by childhood socioeconomic status (SES). We use parental background information from both Add Health and the HRS in order to construct summary indices of childhood SES. The construction of these summary indices is detailed in S1 Appendix. Individuals are classified as High SES and Low SES if the value of their childhood SES index is above and below the median, respectively.

Fig 4 shows how genetic influence on BMI varies by gender and by socio-economic status in the sample of HRS Original cohort members as they age. The life-cycle profile of genetic influence is stable for all subgroups. Additionally, the association between BMIPGS and log(BMI) does not significantly differ neither by gender nor by SES at any point in time.

Fig 4. Association between BMI polygenic scores and Log(BMI) along the life-cycle: Patterns by gender and socioeconomic background.

Fig 4

HRS Original Cohort. This Figure summarizes the results of estimating Eq 2 on the balanced sample of 3,181 HRS Original cohort members described in Table 1 by parental socioeconomic status (SES, in Panel A) and by gender (Panel B). The dependent variable is Log(BMI). OLS coefficient estimates of β1 as well as their associated 95% confidence intervals are depicted. All regressions include age, age squared, and the first 10 principal components of the full matrix of genetic data. Regressions by SES (in Panel A) also include a female dummy as a covariate. Low and High SES individuals are those whose parental socioeconomic status is below and above the median, respectively. Standard errors are clustered at the household level.

The results for the Add Health cohort are depicted in Fig 5. There is a remarkable SES gradient in the influence of BMIPGS: the effect of BMI polygenic scores is significantly stronger for individuals with lower family socioeconomic status than for those with higher socioeconomic status. In contrast, there are no significant differences by gender.

Fig 5. Association between BMI polygenic scores and Log(BMI) along the life-cycle: Patterns by gender and socioeconomic background.

Fig 5

Add Health Cohort. This Figure summarizes the results of estimating Eq 2 on the balanced sample of 2,730 Add Health cohort members described in Table 2 by parental socioeconomic status (SES, in Panel A) and by gender (Panel B). The dependent variable is Log(BMI). OLS coefficient estimates of β1 as well as their associated 95% confidence intervals are depicted. All regressions include age, age squared, and the first 10 principal components of the full matrix of genetic data. Regressions by SES (in Panel A) also include a female dummy as a covariate. Low and High SES individuals are those whose parental socioeconomic status is below and above the median, respectively. Standard errors are clustered at the school level. Longitudinal weights are used.

Regarding life-cycle patterns of genetic influence in Add Health, the conclusions are the same for all subgroups: the association between BMIPGS and log(BMI) significantly increases as adolescents transition into adulthood.

Additional results

Pubertal stage and the association of BMI PGS with BMI

Puberty and BMI are likely related ([53, 54], among others), and pubertal timing differs across individuals. Therefore, part of BMI variation during adolescence may be due to pubertal stage differences across teenage respondents. Hence, the variance of the error in Eq (2) is likely larger for adolescents than for older individuals. Moreover, there is evidence that pubertal timing and BMI have a common genetic component and therefore part of the effect of genes on BMI might be explained by the effect of genes on pubertal timing [55, 56]. To study whether our previous results are affected by these factors, we replicate our baseline analyses including gender-specific information on the stage of development of adolescents that Add Health collected in Waves I and II, as by Wave III individuals were already between 18 and 26 years old (21.7 years old on average in our analytic sample).

In particular, we use the following questions that were asked to boys in Waves I and II: i) “How much hair is under your arms now? 1 I have no hair at all, 2 I have a little hair, 3 I have some hair, but not a lot; it has spread out since it first started, 4 I have a lot of hair that is thick, 5 I have a whole lot of hair that is very thick, as much hair as a grown man”; ii) “How thick is the hair on your face? 1 I have a few scattered hairs, but the growth is not thick, 2 The hair is somewhat thick, but you can still see a lot of skin under it, 3 The hair is thick; you can’t see much skin under it, 4 The hair is very thick, like a grown man’s facial hair”; iii) “Is your voice lower now than it was when you were in grade school? 1 No, it is about the same as when you were in grade school, 2 Yes, it is a little lower than when you were in grade school, 3 Yes, it is somewhat lower than when you were in grade school, 4 Yes, it is a lot lower than when you were in grade school, 5 Yes, it is a whole lot lower than when you were in grade school; it is as low as an adult man’s voice”; and iv) “How advanced is your physical development compared to other boys your age? 1 I look younger than most, 2 I look younger than some, 3 I look about average, 4 I look older than some, 5 I look older than most”.

As for girls, we use the following questions that were asked in Waves I and II: i) “As a girl grows up her breasts develop and get bigger. Which sentence best describes you? 1 My breasts are about the same size as when I was in grade school, 2 My breasts are a little bigger than when I was in grade school, 3 My breasts are somewhat bigger than when I was in grade school, 4 My breasts are a lot bigger than when I was in grade school, 5 My breasts are a whole lot bigger than when I was in grade school, they are as developed as a grown woman’s breasts”; ii) “As a girl grows up her body becomes more curved. Which sentence best describes you? 1 My body is about as curvy as when I was in grade school, 2 My body is a little more curvy than when I was in grade school, 3 My body is somewhat more curvy than when I was in grade school, 4 My body is a lot more curvy than when I was in grade school, 5 My body is a whole lot more curvy than when I was in grade school”; iii) “Have you ever had a menstrual period (menstruated)? 0 No, 1 Yes”; and iv) “How advanced is your physical development compared to other girls your age? 1 I look younger than most, 2 I look younger than some, 3 I look about average, 4 I look older than some, 5 I look older than most”. We construct binary indicators for all the possible answers to these questions and we add them as controls to our estimations of Eq (2) for Waves I and II. The results of this analysis, reported in S1 Appendix of Table 3, indicate that the effect of BMIPGS on log(BMI) is lower after the inclusion of puberty stage controls. This is consistent with the fact that pubertal timing and BMI have a common genetic component. As a consequence, the estimated association between BMIPGS and log(BMI) increases more markedly as individuals transition from adolescence into adulthood when we control for pubertal stage indicators than when we do not (see Fig 3 and/or S1 Appendix of Table 2). While it is reassuring that our conclusion is robust to the addition of pubertal stage indicators, our preferred specification excludes this set of controls in order to avoid reverse causality bias, as there is evidence that childhood obesity increases the risk of premature puberty for girls and boys [54]. Moreover, we re-estimate our benchmark model including pubertal timing as an additional regressor in S1 Appendix of Table 4. Females’ puberty onset is classified as early vs. delayed if age of menarche was lower 13 (which is the median in our sample) vs. 13+. Establishing males’ puberty onset is more complex. We do so following the recommendations from [57]. In particular, we regress a pubertal status index on age, and we then save the residuals. The pubertal status index has been constructed using principal component analysis on the variables related to pubertal stage for boys previously described and measured in Wave I, as they display more variation in Wave I than in Wave II. Males’ puberty onset is subsequently classified as early vs. delayed if the regression’s residuals are below vs. above the median. As the comparison between Columns 1 and 2 of S1 Appendix Table 4 reveals, the inclusion of pubertal timing as a control barely alters the estimated coefficients of BMIPGS. In summary, this evidence indicates that the increasing pattern of association between BMIPGS and log(BMI) we find for Add Health adolescents as they transition into adulthood is robust to the inclusion of controls for pubertal stage and the timing of puberty onset.

Morbidity and the association of BMI PGS with BMI

Chronic diseases are more prevalent among the elderly, and they may in turn lead to wasting (BMI loss). We investigate whether our previous results for HRS Original cohort members are affected by the prevalence of the following conditions: heart disease, cancer, diabetes, lung disease, and arthritis. First, we study how the prevalence of these conditions correlates with both BMI and with BMIPGS in our analytic sample. The prevalence of heart disease, diabetes, and arthritis is positive and significantly correlated with BMI, while the prevalence of cancer, lung disease, and BMI are not significantly correlated. This pattern is the same for all sample years, that is, since individuals are on average 55.9 years old (in 1992) until they reach 71.7 years of age on average (in 2008). Hence, we find no evidence of BMI reductions being linked to higher prevalence of chronic diseases in our sample. The correlation between BMIPGS and chronic diseases is positive and significant for heart disease, diabetes, and arthritis, while it is generally insignificant for cancer and lung disease.

Next, we replicate our baseline analyses including the prevalence of these five chronic conditions as additional controls in all our sample years. The results of this analysis, reported in S1 Appendix Table 5 reveal that the inclusion of this set of controls slightly attenuates the estimated association between BMIPGS and log(BMI). This is consistent with our previous finding that BMIPGS are positively and significantly correlated with several chronic diseases. Importantly, the life-cycle association between BMIPGS and log(BMI) remains stable as individuals transition from middle-age to old-age once these additional controls are included in our benchmark model (2). However, we do not include them in our preferred specification because their relationship with BMI is likely bidirectional.

Robustness checks

Attrition

The longitudinal nature of our analyses implies that there is attrition in both our Add Health and HRS samples. This could be problematic if attrition is systematically related to BMIPGS. We cannot directly test whether this is the case because individuals were not genotyped in the first wave we observe them neither in Add Health (genotyping took place in Wave IV) nor in the HRS (genotyping took place in 2006-08).

We can, however, investigate whether attrition is related to obesity and BMI measured the first time individuals were interviewed. We do so by regressing a binary variable identifying missing individuals due to attrition between the first and the last waves analyzed on initial BMI and obesity. We find that attrition is not significantly related to initial BMI or obesity status neither in Add Health nor in the HRS.

Concerns about attrition due to selective mortality may remain in the HRS because members of the HRS Original cohort (55.9 years old on average the first time we observe them in 1992) may have died by the time genetic data were collected [58, 59], and elevated BMI is known to have adverse health consequences. Actually, if we regress a dummy identifying attrited individuals due to death between the first (1992) and the last wave (2012) analyzed (instead of a dummy identifying overall attrition) on BMI and obesity measured in 1992, the estimated coefficients are positive and significant. Hence, we adjust our benchmark results for the HRS Original cohort by using inverse probability weighting methods as in [59]. Fitted values from a logit survival regression are used to obtain probability weights which are used as inverse probability weights to adjust estimates for selective mortality. In particular, our inverse probability weights are based on fitted values obtained from estimating a logit model of the probability of survival (until genotyping took place) as a function of respondents’ educational attainment, year of birth, and several health indicators (the means of individuals’ BMI, CES depression scale, and self-reported health over all available years, indicators of whether respondents ever reported smoking, having diabetes, and having heart disease, and respondents’ maximum height over all available waves).

The results of this adjustment, presented in Table 6 in S1 Appendix, suggest that our results are robust to selective mortality because they are extremely similar to those obtained in our benchmark analysis.

Objective measurements versus self-reports of weight and height

Objective measurements of height and weight are only available in some waves of Add Health (Waves II, III, IV, and V) and the HRS (2006 and 2008). We use this information to investigate whether it is likely that using self-reports may affect our results, and our findings are reassuring. We show estimation results based on objective BMI measures (whenever available), and compare them with our benchmark results based on subjective BMI measures in Table 7 in S1 Appendix. Panel A of Table 7 in S1 Appendix displays the estimated associations between BMIPGS and objective (Column 1) and self-reported (Column 2) log(BMI) for the HRS Original cohort for years 2006 and 2008 (our sample years with available objective BMI measures). The comparison of Columns 1 and 2 reveals that the estimated associations between BMIPGS and objective and self-reported log(BMI) barely differ. Therefore, our conclusion that the link between BMIPGS and log(BMI) is stable over as middle-age individuals transition to old-age remains when using objective BMI measures. Panel B of Table 7 in S1 Appendix does the same comparative analysis for the Add Health cohort. The estimated coefficients of BMIPGS do not significantly differ (at the 5% level) across columns for all waves. Importantly, our finding that the association between BMIPGS and log(BMI) increases as adolescents transition into adulthood prevails when using objective BMI measures.

Socioeconomic status and the association of BMI PGS with BMI

We now replicate our benchmark analyses including childhood SES among the set of control variables. This allows us to explore further whether the observed life-cycle associations between BMIPGS and log(BMI) reflect similar patterns as association between SES and log(BMI) as individuals grow older. The results of these analyses are shown in Tables 8 and 9 in S1 Appendix.

The association between SES and log(BMI) for Add Health cohort members is negative, significant, and it increases (in absolute terms) as they transition from adolescence into adulthood (Table 8 in S1 Appendix, Column 2). However, the inclusion of SES among the control set barely changes the estimated coefficients BMIPGS (Table 8 in S1 Appendix, comparison of Columns 1 and 3). This indicates that SES effects across the life course cannot explain the observed increasing association between BMIPGS and log(BMI) between adolescence and early adulthood, which remains basically unaltered when SES is held constant.

The association between SES and log(BMI) for HRS Original cohort members is negative and significant, and it does not significantly change as individuals get older (Table 9 in S1 Appendix, Column 2). The inclusion of the childhood SES index among the set of control variables hardly modifies the estimated coefficients of BMIPGS (Table 9 in S1 Appendix, comparison of Columns 1 and 3).

In summary, this evidence indicates that SES cannot account for the life-cycle patterns of association between BMIPGS and log(BMI) we have uncovered so far, neither for Add Health nor for HRS Original cohort members.

Discussion

In this paper we find that the effect of BMI polygenic scores on log(BMI) increases significantly as teenagers transition into adulthood (using the Add Health cohort, born 1974-83). However, this is not the case for individuals aged 55+ who were born in earlier cohorts (HRS Original cohort born 1931-41, War Babies cohort born 1942-47, and Early Baby Boomers cohort born 1948-53), whose life-cycle pattern of genetic influence on BMI is remarkably stable. We uncover similar life-cycle patterns for all the cohorts we study when we separately analyse males and females, and low and high socioeconomic status groups.

One possible explanation for our results is that the effect of BMI polygenic scores on BMI increases until people reach a certain age, and remains stable thereafter. This hypothesis is consistent with [36], who find that the association between genes and BMI peaks in early adulthood.

Interestingly, we also find that the association between BMI polygenic scores and BMI significantly differs by childhood socioeconomic status in the Add Health cohort, while this is not the case in earlier HRS cohorts. In particular, childhood socioeconomic status significantly moderates the effect of BMI polygenic scores for Add Health cohort members. In contrast, the effect of BMI polygenic scores does not significantly differ by gender in any of the cohorts analysed.

Last but not least, our findings also indicate that the effect of BMI polygenic scores on BMI is likely to be non-linear. In fact, the AIC test rejects the linear model in favor of a log-linear model. This simple transformation might be considered when conducting future GWAS in order to improve the predictive power of polygenic scores.

Strengths and limitations

In this paper, we use two longitudinal surveys to provide new evidence on gene-age interaction effects on BMI for several cohorts. In particular, we study teenagers from the Add Health cohort (born 1974-1983) as they transition into adulthood as well as individuals aged 55+ who were born in earlier HRS cohorts (1931-53) as they move into old-age. The use of panel data is crucial in this context because it allows one to disentangle age/time associations from cohort effects. In contrast, as argued by [35], cross-sectional studies may fail to detect age-varying associations as they cannot disentangle age/time from cohort effects. Our analyses are based on different cohorts observed at different stages of the life cycle. Hence, our contrasting findings for Add Health and the HRS may reflect differing patterns of genetic influence along the life cycle, but they could also stem from systematic differences across cohorts in their life-cycle patterns of genetic influence.

Note also that in this paper we estimate a reduced-form model without digging into the mechanisms behind gene-age interactions because of data limitations. Our results therefore could be explained by changes in the biology of BMI across the life course as well as by environmental changes that may reinforce or mitigate the effect of genes on BMI [25, 27, 60]. Understanding the mechanisms behind the patterns we uncover is worth further investigation.

Another limitation of our analyses is that the genome-wide association study employed to compute the BMIPGS used mostly relies on European-descent individuals [20]. Therefore, our results cannot be generalized to individuals from different ancestries. The availability of GWAS for other ancestries would allow to overcome this limitation.

Finally, another potential limitation stems from the fact that the strength of genotype-phenotype associations may vary by age. Hence, GWAS results may not replicate in samples where the age distribution differs from that of the GWAS sample [35]. The BMIPGS we use rely on the GWAS conducted by [20], which is in turn mostly based on a sample of midlife individuals. Hence, their predictive power may be lower for younger individuals. A similar argument may apply to other demographic characteristics like childhood socioeconomic status (as our Add Health results by socioeconomic status suggest). While the strongest BMIPGS-BMI association we uncover is for young adults (Waves 4 and 5 of Add Health), this warrants further investigation.

Supporting information

S1 Appendix. Additional figures and tables and childhood socioeconomic status indices construction.

(PDF)

S1 File

(ZIP)

Acknowledgments

We thank Pedro Albarrán, Dimitris Christelis, and Michael Rosholm for comments and suggestions.

Data Availability

There are legal restrictions on sharing our data set publicly even if it is a de-identified/fully anonymized data set. Hereby you can see the requirements to access the restricted version of the data (which is the one we use) established by the data producers: https://www.cpc.unc.edu/projects/addhealth/contracts; https://hrs.isr.umich.edu/data-products/access-to-public-data/conditions-of-use. If researchers are interested in using these data they must comply with those requirements. We hereby confirm that others would be able to access these data in the same manner we did, and we had no special privileges other would not have. Please submit your requests for data to: addhealth_contracts@unc.edu (for Add Health data) and hrsdapplication@umich.edu (for HRS data).

Funding Statement

Anna Sanz-de-Galdeano acknowledges financial support from PROMETEO/2019/037 and from the Spanish Ministry of Economy and Competitiveness Grant ECO2017-87069-P.

References

  • 1.NHLBI. Managing Overweight and Obesity in Adults: Systematic Evidence Review from the Obesity Expert Panel. National Institutes of Health, U.S. Department of Health and Human Services; 2013.
  • 2. Bhaskaran K, Douglas I, Forbes H, dos Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5· 24 million UK adults. The Lancet. 2014;384(9945):755–765. 10.1016/S0140-6736(14)60892-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Kasen S, Cohen P, Chen H, Must A. Obesity and psychopathology in women: a three decade prospective study. International Journal of Obesity. 2008;32(3):558 10.1038/sj.ijo.0803736 [DOI] [PubMed] [Google Scholar]
  • 4. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of general psychiatry. 2010;67(3):220–229. 10.1001/archgenpsychiatry.2010.2 [DOI] [PubMed] [Google Scholar]
  • 5. Cawley J. The impact of obesity on wages. Journal of Human resources. 2004;39(2):451–474. 10.3368/jhr.XXXIX.2.451 [DOI] [Google Scholar]
  • 6. Brunello G, d’Hombres B. Does body weight affect wages?: Evidence from Europe. Economics & Human Biology. 2007;5(1):1–19. 10.1016/j.ehb.2006.11.002 [DOI] [PubMed] [Google Scholar]
  • 7.Brunello G, Michaud PC, Sanz-de Galdeano A. The rise in obesity across the Atlantic: An economic perspective. 2008;.
  • 8. Cawley J. An economy of scales: A selective review of obesity’s economic causes, consequences, and solutions. Journal of health economics. 2015;43:244–268. [DOI] [PubMed] [Google Scholar]
  • 9. Böckerman P, Cawley J, Viinikainen J, Lehtimäki T, Rovio S, Seppälä I, et al. The effect of weight on labor market outcomes: An application of genetic instrumental variables. Health economics. 2019;28(1):65–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Cawley J. The Oxford handbook of the social science of obesity. Oxford University Press; 2011. [Google Scholar]
  • 11. Cutler DM, Glaeser EL, Shapiro JM. Why have Americans become more obese? Journal of Economic perspectives. 2003;17(3):93–118. 10.1257/089533003769204371 [DOI] [Google Scholar]
  • 12. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behavior genetics. 1997;27(4):325–351. [DOI] [PubMed] [Google Scholar]
  • 13. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiologic reviews. 2007;29(1):49–61. [DOI] [PubMed] [Google Scholar]
  • 14. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature genetics. 2010;42(11):937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Sandholt C, Hansen T, Pedersen O. Beyond the fourth wave of genome-wide obesity association studies. Nutrition & diabetes. 2012;2(7):e37 10.1038/nutd.2012.9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. The American Journal of Human Genetics. 2012;90(1):7–24. 10.1016/j.ajhg.2011.11.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Zaitlen N, Kraft P, Patterson N, Pasaniuc B, Bhatia G, Pollack S, et al. Using extended genealogy to estimate components of heritability for 23 quantitative and dichotomous traits. PLoS genetics. 2013;9(5):e1003520 10.1371/journal.pgen.1003520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Jou C. The biology and genetics of obesity—a century of inquiries. New England Journal of Medicine. 2014;370(20):1874–1877. 10.1056/NEJMp1400613 [DOI] [PubMed] [Google Scholar]
  • 19. Domingue BW, Belsky DW, Harris KM, Smolen A, McQueen MB, Boardman JD. Polygenic risk predicts obesity in both white and black young adults. PloS one. 2014;9(7):e101596 10.1371/journal.pone.0101596 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197 10.1038/nature14177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in 700000 individuals of European ancestry. Human molecular genetics. 2018;27(20):3641–3649. 10.1093/hmg/ddy271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.OECD. Obesity Update. OECD Publishing, https://www.oecd.org/els/health-systems/Obesity-Update-2017.pdf (accessed 18.01.2020); 2017.
  • 23. Boardman JD, Daw J, Freese J. Defining the environment in gene–environment research: Lessons from social epidemiology. American journal of public health. 2013;103(S1):S64–S72. 10.2105/AJPH.2013.301355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Boardman JD, Domingue BW, Blalock CL, Haberstick BC, Harris KM, McQueen MB. Is the gene-environment interaction paradigm relevant to genome-wide studies? The case of education and body mass index. Demography. 2014;51(1):119–139. 10.1007/s13524-013-0259-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Liu H, Guo G. Lifetime socioeconomic status, historical context, and genetic inheritance in shaping body mass in middle and late adulthood. American sociological review. 2015;80(4):705–737. 10.1177/0003122415590627 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Boardman JD, Roettger ME, Domingue BW, McQueen MB, Haberstick BC, Harris KM. Gene-environment interactions related to body mass: School policies and social context as environmental moderators. Journal of Theoretical Politics. 2012;24(3):370–388. 10.1177/0951629812437751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Barcellos SH, Carvalho LS, Turley P. Education can reduce health differences related to genetic risk of obesity. Proceedings of the National Academy of Sciences. 2018;115(42):E9765–E9772. 10.1073/pnas.1802909115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Demerath EW, Choh AC, Johnson W, Curran JE, Lee M, Bellis C, et al. The positive association of obesity variants with adulthood adiposity strengthens over an 80-year period: a gene-by-birth year interaction. Human heredity. 2013;75(2-4):175–185. 10.1159/000351742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Walter S, Mejía-Guevara I, Estrada K, Liu SY, Glymour MM. Association of a genetic risk score with body mass index across different birth cohorts. Jama. 2016;316(1):63–69. 10.1001/jama.2016.8729 [DOI] [PubMed] [Google Scholar]
  • 30. Rosenquist JN, Lehrer SF, O’Malley AJ, Zaslavsky AM, Smoller JW, Christakis NA. Cohort of birth modifies the association between FTO genotype and BMI. Proceedings of the National Academy of Sciences. 2015;112(2):354–359. 10.1073/pnas.1411893111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Rokholm B, Silventoinen K, Tynelius P, Gamborg M, Sørensen TI, Rasmussen F. Increasing genetic variance of body mass index during the Swedish obesity epidemic. PloS one. 2011;6(11):e27135 10.1371/journal.pone.0027135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Rokholm B, Silventoinen K, Ängquist L, Skytthe A, Kyvik KO, Sørensen TI. Increased genetic variance of BMI with a higher prevalence of obesity. PloS one. 2011;6(6):e20816 10.1371/journal.pone.0020816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Khera AV, Chaffin M, Wade KH, Zahid S, Brancale J, Xia R, et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell. 2019;177(3):587–596. 10.1016/j.cell.2019.03.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Belsky DW, Moffitt TE, Houts R, Bennett GG, Biddle AK, Blumenthal JA, et al. Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Archives of pediatrics & adolescent medicine. 2012;166(6):515–521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, et al. On the replication of genetic associations: timing can be everything! The American Journal of Human Genetics. 2008;82(4):849–858. 10.1016/j.ajhg.2008.01.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Hardy R, Wills AK, Wong A, Elks CE, Wareham NJ, Loos RJ, et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Human molecular genetics. 2010;19(3):545–552. 10.1093/hmg/ddp504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.World Health Organization. Obesity: preventing and managing the global epidemic. 894. World Health Organization; 2000. [PubMed]
  • 38.Kuczmarski RJ. 2000 CDC growth charts for the United States; methods and development. 2002;. [PubMed]
  • 39. Belsky DW, Israel S. Integrating genetics and social science: Genetic risk scores. Biodemography and Social Biology. 2014;60(2):137–155. 10.1080/19485565.2014.946591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature genetics. 2006;38(8):904 10.1038/ng1847 [DOI] [PubMed] [Google Scholar]
  • 41. Benjamin DJ, Cesarini D, Chabris CF, Glaeser EL, Laibson DI, Age GSRS, et al. The promises and pitfalls of genoeconomics. Annu Rev Econ. 2012;4(1):627–662. 10.1146/annurev-economics-080511-110939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Firpo S, Fortin NM, Lemieux T. Unconditional quantile regressions. Econometrica. 2009;77(3):953–973. 10.3982/ECTA6822 [DOI] [Google Scholar]
  • 43. Domingue BW, Belsky DW, Fletcher JM, Conley D, Boardman JD, Harris KM. The social genome of friends and schoolmates in the National Longitudinal Study of Adolescent to Adult Health. Proceedings of the National Academy of Sciences. 2018;115(4):702–707. 10.1073/pnas.1711803115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Crosnoe R, Frank K, Mueller AS. Gender, body size and social relations in American high schools. Social Forces. 2008;86(3):1189–1216. 10.1353/sof.0.0004 [DOI] [Google Scholar]
  • 45. De La Haye K, Robins G, Mohr P, Wilson C. Homophily and contagion as explanations for weight similarities among adolescent friends. Journal of Adolescent Health. 2011;49(4):421–427. 10.1016/j.jadohealth.2011.02.008 [DOI] [PubMed] [Google Scholar]
  • 46. Schaefer DR, Simpkins SD. Using social network analysis to clarify the role of obesity in selection of adolescent friends. American journal of public health. 2014;104(7):1223–1229. 10.2105/AJPH.2013.301768 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Brunello G, Sanz-de Galdeano A, Terskaya A. Not Only in My Genes: The Effects of Peers’ Genotype on Obesity. Journal of Health Economics. 2020; p. 102349 10.1016/j.jhealeco.2020.102349 [DOI] [PubMed] [Google Scholar]
  • 48.Biroli P. Genetic and economic interaction in the formation of human capital: the case of obesity. Mimeo. University of Zurich; 2015.
  • 49. Nagata JM, Braudt DB, Domingue BW, Bibbins-Domingo K, Garber AK, Griffiths S, et al. Genetic risk, body mass index, and weight control behaviors: Unlocking the triad. International Journal of Eating Disorders. 2019;52(7):825–833. 10.1002/eat.23083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Jencks C. Heredity, environment, and public policy reconsidered. American Sociological Review. 1980; p. 723–736. 10.2307/2094892 [DOI] [PubMed] [Google Scholar]
  • 51. Yao C, Joehanes R, Johnson AD, Huan T, Esko T, Ying S, et al. Sex-and age-interacting eQTLs in human complex diseases. Human molecular genetics. 2014;23(7):1947–1956. 10.1093/hmg/ddt582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Harris SE, Riggio V, Evenden L, Gilchrist T, McCafferty S, Murphy L, et al. Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936. Aging (Albany NY). 2017;9(12):2489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Ong KK, Bann D, Wills AK, Ward K, Adams JE, Hardy R, et al. Timing of voice breaking in males associated with growth and weight gain across the life course. The Journal of Clinical Endocrinology & Metabolism. 2012;97(8):2844–2852. 10.1210/jc.2011-3445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Solorzano CMB, McCartney CR. Obesity and the pubertal transition in girls and boys. Reproduction (Cambridge, England). 2010;140(3):399 10.1530/REP-10-0119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Elks CE, Perry JR, Sulem P, Chasman DI, Franceschini N, He C, et al. Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nature genetics. 2010;42(12):1077 10.1038/ng.714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nature genetics. 2017;49(6):834–841. 10.1038/ng.3841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Mendle J, Beltz AM, Carter R, Dorn LD. Understanding puberty and its measurement: ideas for research in a new generation. Journal of Research on Adolescence. 2019;29(1):82–95. 10.1111/jora.12371 [DOI] [PubMed] [Google Scholar]
  • 58. Zajacova A, Burgard SA. Healthier, wealthier, and wiser: a demonstration of compositional changes in aging cohorts due to selective mortality. Population research and policy review. 2013;32(3):311–324. 10.1007/s11113-013-9273-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Domingue BW, Belsky DW, Harrati A, Conley D, Weir DR, Boardman JD. Mortality selection in a genetic sample and implications for association studies. International Journal of Epidemiology. 2017;46(4):1285–1294. 10.1093/ije/dyx041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Sanz-de Galdeano A, Terskaya A. Sibling Differences in Educational Polygenic Scores: How Do Parents React? IZA Discussion Paper No. 12375; 2019.

Decision Letter 0

David Meyre

10 Mar 2020

PONE-D-20-03465

Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts

PLOS ONE

Dear Dr Sanz-de-Galdeano

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Apr 24 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

David Meyre

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2) In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3) In your Methods section, please provide additional information about the participant inclusions method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a)  a description of any inclusion/exclusion criteria that were applied to participant inclusion, b) a table of relevant demographic details, c) a statement as to whether your sample can be considered representative of a larger population.

4) We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5)  Thank you for stating the following in the Acknowledgments/(Title page) Section of your manuscript:

[She acknowledges financial support from PROMETEO/2019/037, and

from the Spanish Ministry of Economy and Competitiveness Grant ECO2017-87069-P]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 [The author(s) received no specific funding for this work.]

Please include the updated Funding Statement in your cover letter. We will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This article reports analysis of genetic association with BMI across the life course. The authors ask if genetic associations with BMI are stronger at some ages as compared to others. They use data from two large social surveys that include longitudinal assessments of BMI. The main finding is that genetic associations with BMI are somewhat stronger at older ages up to the 50s/60s, when associations stabilize.

These findings are consistent with previous reports in both the twin and molecular genetic literatures. The authors should note the Belsky et al. 2012 paper, which was the first to report polygenic score associations with BMI development across the first half of the life course. (the Hardy et al. paper cited analyzed only the FTO polymorphism)

The main technical criticism I would make of this analysis is that the authors do not take seriously enough the limitation that much of their data come from self-reports of height and weight. They tell us they did some analysis to evaluate the risk this posed to the inferences they make but don’t show the data. They should.

This is particularly important for interpreting genetic associations with BMI across the transition from adolescence to young adulthood. The adolescent BMI data come from self-reports whereas the young adult data come from anthropometric assessments. If there is less error in measurement in the anthropometry-derived BMIs, this will lead to larger effect-sizes in association analysis.

A second critique is that the authors don’t seem to think much about the biology of BMI change across the life course and how this may affect genetic associations. Two processes are of particular relevance to the analysis reported. First, puberty causes substantial changes in BMI. Pubertal timing varies across individuals. Variation in pubertal timing may therefore result in a kind of measurement error in the BMI phenotype being analyzed in adolescence, biasing genetic effect-sizes toward the null. Second, with advancing age, a range of chronic diseases become more prevalent, leading to wasting (BMI loss). Add Health data on timing of menarche and HRS data on chronic disease morbidity may be helpful in exploring these processes.

Basically, my concern is that the authors are not identifying substantive differences in how genetics affect BMI, but instead are observing variation in the magnitudes of non-genetic causes (or genetic causes not measured in the PGS) across life course stages.

One idea to explore in evaluating this issue is to use some non-genetic measure of risk for obesity. For example, both Add Health and HRS measure parental education, which is associated with BMI across the life course. Do parental education associations with BMI show the same patterns of change with age as genetic associations? If so, is this analysis telling us something about genetics or simply about the sources of systematic variation in BMI? If not, this is a strong piece of evidence that the patterning observed is specifically about the genetics being studied.

MINOR

To my mind, there is a conceptual problem with the article. The authors approach their question within a GxE framework. But the changing association of genetics with BMI as people age is not a GxE. BMI growth is a developmental process, with BMI at later ages strongly influenced by BMI earlier on. Given the authors have repeated measures data on individuals, the question they should be asking is how do BMI genetics influence BMI change across the life course. But this is a matter of taste and differing views of how this problem should be approached ought not to interfere with publication in this journal.

Something else: The polygenic score analyzed by the authors comes from a GWAS that included mainly midlife individuals. For this reason, we might expect the strongest genetic associations in that age range. This might be discussed somewhat more in the introduction and discussion sections of the article.

Reviewer #2: This is an excellent study, well performed and well written, and I recommend its publication.

Statistical methods are explained in detail and results are clear.

There is a typo in the abstract (a duplicated "the").

Congratulations.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

David Meyre

20 Jul 2020

PONE-D-20-03465R1

Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts

PLOS ONE

Dear Dr. Sanz-de-Galdeano,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

More specifically, you must add a 'strengths and limitations' section in the discussion section of your manuscript.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

David Meyre

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Please add a 'strengths and limitations' section in the discussion section.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 17;15(9):e0239067. doi: 10.1371/journal.pone.0239067.r004

Author response to Decision Letter 1


28 Jul 2020

Ref: PONE-D-20-03465

Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts

PLOS ONE

July 26th, 2020

Dear Referees,

Please find enclosed a revised version of the paper, Manuscript Ref PONE-D-20-03465, “Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts”. We thank you and the Editor for your comments, and for giving us the opportunity to revise the paper. We believe the paper has considerably improved as a result. Further details are in our point-to-point reply letters that follow.

Yours sincerely,

The authors

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

More specifically, you must add a 'strengths and limitations' section in the discussion section of your manuscript.

We have added a section “strengths and limitations” in page 14, which includes the following points:

1. In this paper, we use two longitudinal surveys to provide new evidence on gene-age interaction effects on BMI for several cohorts. In particular, we study teenagers from the Add Health cohort (born 1974-1983) as they transition into adulthood as well as individuals aged 55+ who were born in earlier HRS cohorts (1931-53) as they move into old-age. The use of panel data is crucial in this context because it allows one to disentangle age/time associations from cohort effects. In contrast, as argued by (Lasky-Su et. al., 2008), cross-sectional studies may fail to detect age-varying associations as they cannot disentangle age/time from cohort effects.

Our analyses are based on different cohorts observed at different stages of the life cycle. Hence, our contrasting findings for Add Health and the HRS may reflect differing patterns of genetic influence along the life cycle, but they could also stem from systematic differences across cohorts in their life-cycle patterns of genetic influence.

2. Note also that in this paper we estimate a reduced-form model without digging into the mechanisms behind gene-age interactions because of data limitations. Our results therefore could be explained by changes in the biology of BMI across the life course as well as by environmental changes that may reinforce or mitigate the effect of genes on BMI (Sanz‐de‐Galdeano and Terskaya, 2019; Liu et. al. 2015; Barcellos et. al, 2018). Understanding the mechanisms behind the patterns we uncover is worth further investigation.

3. Another limitation of our analyses is that the genome-wide association study employed to compute the BMIPGS used mostly relies on European-descent individuals (Locke at. al., 2015). Therefore, our results cannot be generalized to individuals from different ancestries. The availability of GWAS for other ancestries would allow to overcome this limitation.

4. Finally, another potential limitation stems from the fact that the strength of genotype-phenotype associations may vary by age. Hence, GWAS results may not replicate in samples where the age distribution differs from that of the GWAS sample (Lasky-Su et. al., 2008). The BMIPGS we use rely on the GWAS conducted by Locke at. al. (2015). which is in turn mostly based on a sample of midlife individuals. Hence, their predictive power may be lower for younger individuals. A similar argument may apply to other demographic characteristics like childhood socioeconomic status (as our Add Health results by socioeconomic status suggest). While the strongest BMIPGS-BMI association we uncover is for young adults (Waves 4 and 5 of Add Health), this warrants further investigation.

Barcellos SH, Carvalho LS, Turley P. Education can reduce health differences related to genetic risk of obesity. Proceedings of the National Academy of Sciences. 2018;115(42):E9765-E9772.

Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, et al. On the replication of genetic associations: timing can be everything! The American Journal of Human Genetics. 2008;82(4):849-858.

Liu H, Guo G. Lifetime socioeconomic status, historical context, and genetic inheritance in shaping body mass in middle and late adulthood. American sociological review. 2015;80(4):705-737.

Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197.

Sanz-de Galdeano A, Terskaya A. Sibling Differences in Educational Polygenic Scores: How Do Parents React? IZA Discussion Paper No. 12375; 2019

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

David Meyre

31 Aug 2020

Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts

PONE-D-20-03465R2

Dear Dr. Sanz-de-Galdeano,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

David Meyre

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

David Meyre

4 Sep 2020

PONE-D-20-03465R2

Association of a Genetic Risk Score with BMI along the Life-Cycle: Evidence from several US Cohorts 

Dear Dr. Sanz-de-Galdeano:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. David Meyre

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Additional figures and tables and childhood socioeconomic status indices construction.

    (PDF)

    S1 File

    (ZIP)

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    There are legal restrictions on sharing our data set publicly even if it is a de-identified/fully anonymized data set. Hereby you can see the requirements to access the restricted version of the data (which is the one we use) established by the data producers: https://www.cpc.unc.edu/projects/addhealth/contracts; https://hrs.isr.umich.edu/data-products/access-to-public-data/conditions-of-use. If researchers are interested in using these data they must comply with those requirements. We hereby confirm that others would be able to access these data in the same manner we did, and we had no special privileges other would not have. Please submit your requests for data to: addhealth_contracts@unc.edu (for Add Health data) and hrsdapplication@umich.edu (for HRS data).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES